{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:22Z","timestamp":1794017242114,"version":"4.8.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.berh.2024.101938","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:29:47Z","timestamp":1708561787000},"page":"101938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-8315","authenticated-orcid":false,"given":"Matteo","family":"Piga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostantinos","family":"Tselios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray Barry","family":"Urowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.101938_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2024.101938_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","article-title":"Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies","volume":"74","author":"Lu","year":"2016","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.berh.2024.101938_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.40004","article-title":"Discerning risk of disease transition in relatives of systemic lupus erythematosus patients utilizing soluble mediators and clinical features","volume":"69","author":"Munroe","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.41935","article-title":"Association of a combination of healthy lifestyle behaviors with reduced risk of incident systemic lupus erythematosus","volume":"74","author":"Choi","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib5","article-title":"Life factors acting on systemic lupus erythematosus","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101938_bib6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0961203318778368","article-title":"Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus","volume":"27","author":"Young","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/41.5.563","article-title":"Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden","volume":"41","author":"Bengtsson","year":"2002","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.berh.2024.101938_bib8","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/rheumatology\/keq214","article-title":"Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents","volume":"49","author":"Cooper","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.berh.2024.101938_bib9","doi-asserted-by":"crossref","unstructured":"Barbhaiya M, Hart JE, Malspeis S, et al. Association of ultraviolet B radiation and risk of systemic lupus erythematosus among women in the nurses' health studies. Arthritis Care Res;n\/a. doi:10.1002\/acr.24974.","DOI":"10.1002\/acr.24974"},{"key":"10.1016\/j.berh.2024.101938_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2017-211675","article-title":"Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts","volume":"77","author":"Barbhaiya","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10067-015-3008-9","article-title":"Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis","volume":"34","author":"Jiang","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.semarthrit.2018.10.004","article-title":"A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among black women","volume":"48","author":"Cozier","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","article-title":"The risk of systemic lupus erythematosus associated with Epstein\u2013Barr virus infection: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2019","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.berh.2024.101938_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780400505","article-title":"Past use of oral contraceptives and the risk of developing systemic lupus erythematosus","volume":"40","author":"Sanchez-Guerrero","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.10368","article-title":"Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States","volume":"46","author":"Parks","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41598-020-79954-z","article-title":"Association between endometriosis and risk of systemic lupus erythematosus","volume":"11","author":"Fan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2024.101938_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1177\/0961203318805844","article-title":"Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women","volume":"27","author":"Williams","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/acr.22282","article-title":"Modifying effect of N-acetyltransferase 2 genotype on the association between systemic lupus erythematosus and consumption of alcohol and caffeine-rich beverages","volume":"66","author":"Kiyohara","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.101938_bib20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of anti-nuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/acr.23292","article-title":"Performance of anti-nuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data","volume":"70","author":"Leuchten","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib22","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib23","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/art.40674","article-title":"Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria","volume":"71","author":"Mosca","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.berh.2024.101938_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","article-title":"SLE diagnosis and treatment: when early is early","volume":"10","author":"Doria","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101938_bib26","first-page":"1332","article-title":"Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease","volume":"18","author":"Alarc\u00f3n","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/acr.23894","article-title":"Incomplete systemic lupus erythematosus: what remains after application of American college of rheumatology and systemic lupus international collaborating clinics criteria?","volume":"72","author":"Lambers","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000843","article-title":"Genetic load in incomplete lupus erythematosus","volume":"10","author":"Slief","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2024.101938_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48\u201349","author":"Mosca","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2024.101938_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","article-title":"Differentiating between UCTD and early-stage SLE: from definitions to clinical approach","volume":"18","author":"Sciascia","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103184","article-title":"Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: a systematic review and meta-analysis","volume":"21","author":"Dyball","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101938_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s13063-018-3076-7","article-title":"Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial","volume":"19","author":"Olsen","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.berh.2024.101938_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221100300","article-title":"Validation of the 2019 EULAR\/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients","volume":"14","author":"Chung","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.berh.2024.101938_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000176","article-title":"Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus","volume":"4","author":"Aberle","year":"2017","journal-title":"Lupus science & medicine"},{"key":"10.1016\/j.berh.2024.101938_bib37","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1093\/rheumatology\/keac120","article-title":"The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department","volume":"61","author":"Tan","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101938_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001097","article-title":"Applying the 2019 EULAR\/ACR lupus criteria to patients from an established cohort: a Latin American perspective","volume":"6","author":"Pons-Estel","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101938_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/annrheumdis-2019-216155","article-title":"In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment","volume":"79","author":"Adamichou","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000718","article-title":"Utility of the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study","volume":"9","author":"Lu","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2024.101938_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/acr.22484","article-title":"We need better classification and terminology for \u201cpeople at high risk of or in the process of developing lupus.\u201d","volume":"67","author":"Costenbader","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/annrheumdis-2020-219069","article-title":"Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus","volume":"80","author":"Adamichou","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib43","first-page":"74","article-title":"From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study","volume":"41","author":"Kapsala","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/acr.23021","article-title":"Early clinical features in systemic lupus erythematosus : can they Be used to achieve earlier diagnosis ? A risk prediction model","volume":"69","author":"Rees","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib45","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/rheumatology\/keac005","article-title":"Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease","volume":"61","author":"Erden","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101938_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40258-014-0085-x","article-title":"Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes","volume":"12","author":"Oglesby","year":"2014","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.berh.2024.101938_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13075-017-1451-5","article-title":"Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus","volume":"19","author":"Piga","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.101938_bib48","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/acr.24086","article-title":"Treatment target in newly diagnosed systemic lupus erythematosus: the association of lupus low disease activity state and remission with lower accrual of early damage","volume":"72","author":"Floris","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib49","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/rheumatology\/kez584","article-title":"Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort","volume":"59","author":"Piga","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.berh.2024.101938_bib50","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/096120301670679959","article-title":"Early damage as measured by the SLICC\/ACR damage index is a predictor of mortality in systemic lupus erythematosus","volume":"10","author":"Rahman","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002701","article-title":"Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study","volume":"8","author":"Floris","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101938_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0961203318817132","article-title":"Disease course patterns in systemic lupus erythematosus","volume":"28","author":"Tselios","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib54","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6","article-title":"Patterns of disease activity in systemic lupus erythematosus","volume":"42","author":"Barr","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000192","article-title":"Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort","volume":"4","author":"Gy\u00f6ri","year":"2017","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2024.101938_bib56","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3899\/jrheum.171319","article-title":"Monophasic disease course in systemic lupus erythematosus","volume":"45","author":"Tselios","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib57","first-page":"856","article-title":"Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study","volume":"30","author":"Zen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib58","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1136\/annrheumdis-2015-207347","article-title":"Prolonged remission in Caucasian patients with SLE: prevalence and outcomes","volume":"74","author":"Zen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3899\/jrheum.130005","article-title":"Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment","volume":"41","author":"Touma","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib60","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.24741","article-title":"Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus","volume":"61","author":"Nikpour","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib61","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/acr.23191","article-title":"Medication nonadherence in systemic lupus erythematosus: a systematic review","volume":"69","author":"Mehat","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","article-title":"Adherence to treatment in systemic lupus erythematosus patients","volume":"27","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib63","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/0961203317693096","article-title":"Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years","volume":"26","author":"Taraborelli","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib64","first-page":"700","article-title":"A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors","volume":"35","author":"Nevskaya","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203316664597","article-title":"Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus","volume":"26","author":"Cramarossa","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the systemic lupus international collaborating clinics\/American College of rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2","article-title":"Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group","volume":"45","author":"Alarc\u00f3n","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib68","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/annrheumdis-2016-210154","article-title":"The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients","volume":"76","author":"Zen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib69","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib70","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.semarthrit.2018.10.013","article-title":"How can we define low disease activity in systemic lupus erythematosus?","volume":"48","author":"Tselios","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib71","first-page":"856","article-title":"Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study","volume":"30","author":"Zen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib72","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/acr.23109","article-title":"Defining low disease activity in systemic lupus erythematosus","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib73","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a lupus low disease activity state (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib74","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/annrheumdis-2017-211613","article-title":"Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission","volume":"77","author":"Zen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib75","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.23720","article-title":"Clinical remission and low disease activity outcomes over 10 Years in systemic lupus erythematosus","volume":"71","author":"Tselios","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/acr.21568","article-title":"Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period","volume":"64","author":"Steiman","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101938_bib77","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.autrev.2014.01.055","article-title":"Optimizing outcome in SLE: treating-to-target and definition of treatment goals","volume":"13","author":"Doria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101938_bib78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9343(79)90529-1","article-title":"Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features","volume":"66","author":"Gladman","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2024.101938_bib79","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3899\/jrheum.140796","article-title":"Anti-dsDNA and antichromatin antibody isotypes in serologically active clinically quiescent systemic lupus erythematosus","volume":"42","author":"Steiman","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib80","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.150040","article-title":"Lack of interferon and pro-inflammatory cyto\/chemokines in serologically active clinically quiescent systemic lupus erythematosus","volume":"42","author":"Steiman","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib81","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2017.07.012","article-title":"The serine\/threonine protein phosphatase 2A controls autoimmunity","volume":"186","author":"Sharabi","year":"2018","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.berh.2024.101938_bib83","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101938_bib84","first-page":"119","article-title":"Clinical disease activity and flare in SLE: current concepts and novel biomarkers","author":"Thanou","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2024.101938_bib85","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/1744666X.2017.1327352","article-title":"Epidemiology of systemic lupus erythematosus","volume":"13","author":"Pons-Estel","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101938_bib86","first-page":"145","article-title":"Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus","volume":"41","author":"Prevete","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib87","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0961203312450087","article-title":"Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review","volume":"21","author":"Alonso","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0961203317716789","article-title":"Late-onset systemic lupus erythematosus: is it \"mild lupus\"?","volume":"27","author":"Sohn","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00296-006-0284-3","article-title":"Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages","volume":"27","author":"Padovan","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.101938_bib90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00296-016-3450-2","article-title":"Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register","volume":"36","author":"Sousa","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.101938_bib91","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/0961203315591024","article-title":"Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients","volume":"24","author":"Choi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib92","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/rheumatology\/keaa477","article-title":"Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)","volume":"60","author":"Riveros Frutos","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.berh.2024.101938_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14840-4","article-title":"Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study","volume":"12","author":"Wen","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2024.101938_bib94","first-page":"788","article-title":"Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population","volume":"33","author":"Mart\u00ednez-Barrio","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10067-016-3478-4","article-title":"Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus","volume":"36","author":"Sassi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101938_bib96","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/09612033221100908","article-title":"Comorbidities of systemic lupus erythematosus prior to and following diagnosis in different age-at-onset groups","volume":"31","author":"Yu","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0961203313513508","article-title":"Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus","volume":"23","author":"Feng","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101938_bib98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semarthrit.2018.01.010","article-title":"Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis","volume":"48","author":"Medlin","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101938_bib99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/08916934.2013.794793","article-title":"Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus","volume":"46","author":"Cartella","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2024.101938_bib100","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3899\/jrheum.101088","article-title":"Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China","volume":"38","author":"Feng","year":"2011","journal-title":"J Rheumatol"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:53:42Z","timestamp":1718812422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521694224000093"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101938","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101938"}}